Key result
Missing cardiovascular prescriptions at discharge is linked to ~73% fewer subsequent fills post-MI.
Why the study?
Individuals with type 2 diabetes have high mortality after MI, and hospitalization offers an opportunity to initiate or continue evidence-based risk-reducing therapy.
Cohort (n=188,651)
Effect estimate: aRR 0.27 (95% CI 0.27-0.28)
In Medicare beneficiaries with type 2 diabetes hospitalized for MI or coronary revascularization, prescription of evidence-based cardiovascular medications at discharge is strongly associated with continued medication use 91-180 days post-discharge.
No takes yet. Share an insight, caveat, or question.
Discharge prescriptions may predict post-MI continuity in older T2D patients; leaves open whether targeting discharge improves adherence.
Kelsey et al. (2024) conducted a cohort in Type 2 diabetes and acute coronary syndrome (n=188,651). Prescription fill at discharge vs. No prescription fill at discharge was evaluated on Lack of prescription fills in the postdischarge period (91-180 days) (aRR 0.27, 95% CI 0.27-0.28). Not filling a cardiovascular medication after hospitalization for MI or revascularization was associated with not filling it at discharge (aRR 0.27; 95% CI 0.27-0.28 for ACEIs/ARBs/ARNIs).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: